Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Actym Therapeutics
Actym Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Actym Therapeutics
Total Funding
$34 M
Actym Therapeutics Summary
Company Summary
Overview
Actym Therapeutics is a preclinical immuno-oncology company. Its services mainly focus on engineering immunotherapies to treat cancer. The company aims to enable patients to have access to better forms of cancer treatment.
Type
Private
Status
Active
Founded
2017
HQ
Berkeley, CA, US
|
view all locations
Website
https://www.actymthera.com/
Cybersecurity rating
Sectors
Healthcare
biotech
healthtech
oncology
therapy
Homepage
Linkedin
twitter
Table of Contents
Locations
Competitors
Locations
View all
1 location detected
Berkeley, CA
HQ
United States
626 Bancroft Way suite a
Competitors and Similar Companies
Tizona Therapeutics
Healthcare - Private
PIC Therapeutics
Healthcare - Private
ROME Therapeutics
Healthcare - Private
Akston Biosciences
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top